Ocugen Inc (OCGN)
$8.92
0.60 (7.21%)
OCGN Stock Quote Delayed 30 Minutes
7 Robinhood Stocks You Shouldn’t Touch With a 10-Foot Pole
These Robinhood stocks look fundamentally weak and are positioned for downside. They are likely to disappoint even in a bull market.
Louis Navellier's Top 6 Stocks for 2021
He found Apple at $1.49… Intel at $3.60... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 6 Stocks for 2021 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
1.77B
PE Ratio
-40.55
EPS
-0.22
Volume (Avg. Vol.)
17.74M
Day's Range
8.20 - 9.36
52-Week Range
0.25 - 18.77
Dividend & Yield
N/A (N/A)
OCGN Stock Predictions, Articles, and Ocugen Inc News
4 Top Stock Trades for Monday: New All-Time Highs Coming for Bitcoin
Bitcoin, TaskUs, Marathon Digital and Ocugen were our top stock trades going into the weekend. So, here's a look at how the charts are now.
Ocugen Is a Strong Sell, Vaccine Unlikely to Find Commercial Success
Ocugen has historically had a terrible track record. There's little reason to think its current vaccine effort will end any better for OCGN stock.
OCGN Stock: One Big Reason Why Ocugen Is Climbing Today
Covid-19 vaccine play Ocugen is seeing impressive investor interest today, with OCGN stock seeing double-digit gains at the time of writing.
Ocugen Stock Needs a Catalyst for Growth That Probably Isn’t Coming
InvestorPlace’s Louis Navellier believes all Ocugen needs is a catalyst. On Oct. 4, OCGN stock got two. Its share price barely moved.
Hot Penny Stocks for Tuesday: Today’s 10 Biggest Movers
Penny stocks are on the move Tuesday and we're taking a look at what's hot among traders of the volatile investments today.
OCGN Stock: One Big Reason Ocugen Is Powering Higher Today
OCGN stock is making its investors quite happy this morning and prompting many more to pile in. The company is receiving crucial approval.
Ocugen Will Have Value If Its Covid Vaccine Can Get Approved
OCGN stock could be at a full value today given its revenue prospects but could still rise if its Covaxin vaccine gains approval outside India.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, investor! We're getting right into the thick of it today with a look at the biggest pre-market stock movers for Tuesday!
Don’t Buy Too Much Into the WHO Hype Surrounding Ocugen Stock
Admittedly, one last boost may still be on the table, if meme traders use subsequent WHO news as reason to send OCGN stock back to double-digit prices. But with its high chances of ultimately collapsing in price, it's a stock most investors should avoid.
5 Top Stock Trades for Tuesday: SOFI, LUV, TSLA, T, OCGN
SoFi, Southwest Airlines, Tesla, AT&T and Ocugen were our top stock trades for Tuesday. Now, let's look at how the charts are setting up.
Ocugen Bulls Are Overlooking Its FDA Approval Hurdles
The FDA seems highly unlikely to approve the Covaxin vaccine, making OCGN stock an excellent name to short going forward.
OCGN Stock: 2 Huge Reasons Ocugen Stock Is Shooting Higher Today
OCGN stock is surging on some big news. The World Health Organization could give the company the go-ahead on its Covid-19 vaccine very soon.
WHO Approval Won’t Move Ocugen Stock Very Much Over the Long Term
The WHO's nod of approval wont be fruitful to OCGN stock in blowing past the regulatory hurdles in the North American Covid 19 vaccine market
Ocugen Stock Just Needs a Catalyst to Break Free
OCGN stock holders should be patient as the World Health Organization's potential approval of an important vaccine could happen soon.
It’s Time To Drop Ocugen Stock While You Still Can
Hope is one thing, but for investors in OCGN stock expecting regulators or other bulls to come to the rescue is looking less likely
Ocugen Still Lacks a Path to U.S. Profits
Ocugen still lacks a proper catalyst and nothing has changed for it. As a result, investors should avoid OCGN stock.
It’s OK to Sell the News on Ocugen and Covaxin
OCGN stock jumped when Covaxin received WHO approval. But with two major obstacles in the way of U,S. approval, you should sell the news.
WHO Approval Should Get Ocugen Stock Over the $15 Barrier
Sharp up-and-down moves in OCGN stock shouldn't scare investors away, as a regulator's nod for Covaxin should put the stock back on track.
